long term effects of glp 1 agonists GLP-1 For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Glucagon-like Receptor-1 agonists for obesity:

A candid limitations section is essential for a compound at this evidence tier

doi: 10.3389/fmicb.2024.1490064 Received 02 September 2024 Accepted 21 October 2024 Published 11 November 2024 Volume 15 - 2024 Edited by Roshan Kumar, Medical College of Wisconsin, United States Reviewed by Tarique Hussain, Nuclear Institute for Agriculture and Biology, Pakistan Chaoyue Wen, Hunan Agricultural University, China Updates Copyright 2024 Liu, Yang, Wang, Jiang, Du, Hao, Chen, Zhu, Liu, Niu, Zhao, Wang, Gan, Shen and Zhu

10.1111/j.1439-0272.2008.00897.x 100

The unique formula in GlutaShield includes nutrients that support the gut mucosal epithelium